Rationale and design for the Kallikrein Inhibitor in Netherton Syndrome (KINS) pivotal clinical trial Johnson, K. W., Hovnanian, A., Teng, J., Paller, A. S., Choate, K., Elias, P., Laura, Z., Nguyen, T., Smith, D., Hsu, A., Alani, L., Lai, C., Hsu, L. ELSEVIER SCIENCE INC. 2020: S79

View details for Web of Science ID 000554564400510